Search Index
Search this site
370 results found
- Geoengineering as a solution to the climate crisis | Scientia News
For centuries, we have been burning fossil fuels, polluting our oceans and participating in deforestation without a second thought. We have managed to understand the consequences this has had on our planet and have started to make movement in the right direction; but is it too late? Go back Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Geoengineering: what is it and will it actually work? Last updated: 01/03/26 Published: 02/04/23 For centuries, we have been burning fossil fuels, polluting our oceans and participating in deforestation without a second thought. We have managed to understand the consequences this has had on our planet and have started to make movement in the right direction; but is it too late? In the past 50 years, we have warmed the planet at a rate of approximately 0.1°C per decade. It doesn’t sound like much but the effect this has is astronomical; increased drought, adverse weather conditions and a rising sea level to name a few of the consequences. People are aware of the damage we have caused, and there is thankfully a switching attitude towards our environment with the increased usage of renewable energies and technologies such as electric cars. The problem arises from the rate of this societal switch. It isn’t fast enough. We haven’t quite understood how to stop our reliance on farming animals, carbon dioxide emissions and polluting transport. What if we could disrupt the natural mechanisms of our planet, just as we did to cause this problem in the first place? Scientists have started to consider some dystopian sounding scenarios that are classed as ‘geoengineering’ techniques. There are two main branches of geoengineering: solar radiation management and greenhouse gas removal. Solar radiation management is the more alien of the two categories, involving sending large mirrors into space that reflect sunlight or enhancing the natural ability of clouds to block radiation, called albedo enhancement. Greenhouse gas removal is more commonly heard of, and involves reducing the proportion of harmful gases, mainly carbon dioxide, in our atmosphere. This can be as simple as planting more trees to do this naturally, or having point source removal of carbon dioxide in factories, which means that the gases never enter the atmosphere. A difficult yet promising idea is the removal of carbon dioxide directly from the atmosphere using a material that absorbs it directly, which could not only reduce the amount in the atmosphere, but could return us to anthropogenic atmosphere composition. The idea is interesting; to disrupt the naturally occurring processes with human intervention, which buys time for us to develop better renewable energy resources, biodegradable materials and a better attitude towards saving our planet. Theoretically, it seems reasonable however the concern is that with these techniques, we may continue to treat the environment with a lack of respect, since we would be creating a false sense of security. Furthermore, the technologies are large scale therefore we may not be able to model and test them sufficiently before implementation. They may not be successful or safe. The ideal scenario is to not need geoengineering, however we need to act fast to avoid its necessity. Written by Megan Martin Related article: How nuclear fusion holds the key to tackling climate change
- Can a human brain be linked to a computer? | Scientia News
When we think of bacteria, we tend to focus on their pathogenicity and ability to cause diseases such as tuberculosis, which infects around one-quarter of the world’s population. However, whilst bacteria do have the potential to become parasitic, if the trillions of bacterial cells that make up the human microbiome ceased to exist, human health would experience a rapid decline. Go back Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Why bacteria are essential for human survival Last updated: 03/03/26 Published: 13/04/23 When we think of bacteria, we tend to focus on their pathogenicity and ability to cause diseases such as tuberculosis, which infects around one-quarter of the world’s population. However, whilst bacteria do have the potential to become parasitic, if the trillions of bacterial cells that make up the human microbiome ceased to exist, human health would experience a rapid decline. One reason for this is due to the critical role bacteria play in inducing the immune system against pathogenic threats. Upon viral infection, the interferon (IFN) defence system is initiated where the synthesis of antiviral cytokines is upregulated. Evidence suggests bacteria in the gut are capable of modulating the IFN system. They work by inducing macrophages and plasmacytoid dendritic cells to express type 1 IFN, which in turn primes natural killer cells and prepares cytotoxic CD8+ T cells for action. Erttmann et al (2022) demonstrate that a depletion of the gut microbiota diminishes the cell signalling pathways modulated by these commensal bacteria. This causes a reduction in type 1 IFN production, and thus an impairment in the activation of NK and CD8+ T cells. As a result, the body becomes more susceptible to attack by viral infections and less able to defend itself. In fact, the 2025 Nobel Prize for Physiology or Medicine was awarded to Mary Brunkow, Fred Ramsdell and Shimon Sakaguchi for fundamental work on regulatory T-cells; these cells are linked to the microbiome. It proves that certain gut bacteria upregulate Foxp3 transcription, which prevents the immune system from attacking the body. This highlights just how vital the role bacteria in our microbiome play in providing us with innate immunity against viral pathogens and protecting our health. This also brings attention to our use of antibiotics, and the potential negative effects they may have on the commensal bacteria residing in our body. Erttmann et al (2022) further showed that mice treated with a variety of antibiotics exhibited a major reduction in gut microbiota diversity, thus severely comprising their ability to fight off viral infections. Research like this is important in informing doctors to be sensible in their administration of antibiotics, as well as informing patients to not self-medicate and unnecessarily ingest antibiotics. Ultimately, the commensal bacteria living in our bodies play essential roles in protecting human health, and it is, therefore, vital we take the necessary steps to also protect these remarkable microorganisms in return. Written by Bisma Butt Related article: The rising threat of antibiotic resistance REFERENCES Erttmann, S.F., Swacha, P., Aung, K.M., Brindefalk, B., Jiang, H., Härtlova, A., Uhlin, B.E., Wai, S.N. and Gekara, N.O., 2022. The gut microbiota prime systemic antiviral immunity via the cGAS-STING-IFN-I axis. Immunity, 55(5), pp.847-861. Ganal, S.C., Sanos, S.L., Kallfass, C., Oberle, K., Johner, C., Kirschning, C., Lienenklaus, S., Weiss, S., Staeheli, P., Aichele, P. and Diefenbach, A., 2012. Priming of natural killer cells by nonmucosal mononuclear phagocytes requires instructive signals from commensal microbiota. Immunity, 37(1), pp.171-186.
- The exciting potential of mRNA vaccines | Scientia News
Unleashing the power of mRNA: revolutionising medicine with personalised vaccines Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link The exciting potential of mRNA vaccines 11/07/25, 11:03 Last updated: Published: 03/12/24, 12:19 Unleashing the power of mRNA: revolutionising medicine with personalised vaccines Basic mRNA vaccine pharmacology Basic mRNA vaccine pharmacology involves the study of two types of RNA used as vaccines: non-replicating mRNA and self-amplifying RNA. Non-replicating mRNA-based vaccines encode the antigen of interest and contain untranslated regions (UTRs) at both ends. Self-amplifying RNAs, on the other hand, encode both the antigen and the viral replication machinery, allowing for intracellular RNA amplification and abundant protein expression. For successful protein production in mRNA therapeutics, the optimal translation of in vitro transcribed (IVT) mRNA is crucial. Factors such as the length of the poly(A) tail, codon usage, and sequence optimisation can influence translation efficiency and accuracy. Adding an optimal length of poly(A) to mRNA is necessary for efficient translation. This can be achieved by directly incorporating it from the encoding DNA template or by using poly(A) polymerase. Codon usage also plays a role in protein translation. Replacing rare codons with frequently used synonymous codons, which have abundant cognate tRNA in the cytosol, can enhance protein production from mRNA. However, the accuracy of this model has been subject to questioning. Optimally translated IVT mRNA encoding mRNA IVT mRNA plays a crucial role in mRNA vaccines as it is designed for optimal translation, ensuring efficient protein production. To achieve this, a 5ʹ cap structure is added, which is essential for efficient protein synthesis. Different versions of 5ʹ caps can be added during or after the transcription process. Furthermore, the poly(A) tail plays a significant regulatory role in mRNA translation and stability. Sequence optimisation is another critical factor that can enhance mRNA levels and protein expression. Increasing the G:C content has been shown to elevate steady-state mRNA levels in vitro and improve protein expression in vivo. Furthermore, modifying the codon composition or introducing modified nucleosides can positively influence protein expression. However, it is important to note that these sequence engineering techniques may impact mRNA secondary structure, translation kinetics, accuracy, protein folding, as well as the expression of alternative reading frames and cryptic T-cell epitopes. Sequence optimisation for protein translation Sequence optimisation plays a crucial role in the development of mRNA vaccines. It involves modifying the mRNA sequence to improve the efficiency of protein translation. By optimising the sequence, researchers can enhance the expression and stability of therapeutic mRNAs. However, the immunogenicity of exogenous mRNA is a concern, as it can trigger a response from various innate immune receptors. In some cases, encoding mRNA in the hypothalamus may even elicit a physiological response. Despite initial promising outcomes, the development of mRNA therapeutics has been hindered by concerns regarding mRNA instability, high innate immunogenicity, and inefficient in vivo delivery. As a result, DNA-based and protein-based therapeutic approaches have been preferred in the past. Modulation of immunogenicity Modulation of immunogenicity is a crucial aspect of mRNA vaccine development. Researchers aim to design mRNA vaccines that elicit a strong immune response while minimising adverse reactions. This involves careful selection of antigens and optimisation of the mRNA sequence to enhance immunogenicity. Self-replicating RNA vaccines and adjuvant strategies, such as TriMix, have shown increased immunogenicity and effectiveness. The immunostimulatory properties of mRNA can be further enhanced by including adjuvants. The size of the mRNA-carrier complex and the level of innate immune sensing in targeted cell types can influence the immunogenicity of mRNA vaccines. Advantages of mRNA vaccines mRNA vaccines offer several advantages over conventional vaccine approaches. First, they have high potency, meaning they can induce a strong immune response. Second, they have a capacity for rapid development, allowing for quick vaccine production in response to emerging infectious diseases or new strains. Third, mRNA vaccines have the potential for rapid, inexpensive, and scalable manufacturing, mainly due to the high yields of in vitro transcription reactions. Additionally, mRNA vaccines are minimal genetic vectors, avoiding anti-vector immunity, and can be administered repeatedly. However, recent technological innovations and research investments have made mRNA a promising therapeutic tool in vaccine development and protein replacement therapy. mRNA has several advantages over other vaccine platforms, including safety and efficacy. It is non-infectious and non-integrating, reducing the risk of infection and insertional mutagenesis. mRNA can be regulated in terms of in vivo half-life and immunogenicity through various modifications and delivery methods. Production of mRNA vaccines The production of mRNA vaccines involves in vitro transcription (IVT) of the optimised mRNA sequence. This process allows for the rapid and scalable manufacturing of mRNA vaccines. High yields of IVT mRNA can be obtained, making the production process cost-effective. Making mRNA more stable and highly translatable is achievable through modifications. Efficient in vivo delivery can be achieved by formulating mRNA into carrier molecules. The choice of carrier and the size of the mRNA-carrier complex can also modulate the cytokine profile induced by mRNA delivery. Current mRNA vaccine approaches (Figure 1) There are several current mRNA vaccine approaches being explored. These include the development of mRNA vaccines against infectious diseases and various types of cancer. mRNA vaccines have shown promising results in both animal models and humans. Cancer vaccines Cancer vaccines are a type of immunotherapy that aim to stimulate the body's immune system to recognise and destroy cancer cells. These vaccines work by introducing specific antigens, which are substances that can stimulate an immune response, into the body. The immune system then recognises these antigens as foreign and mounts an immune response against them, targeting and destroying cancer cells that express these antigens. There are different types of cancer vaccines, including personalised vaccines and predefined shared antigen vaccines. Personalised vaccines are tailored to each patient and are designed to target specific mutations or antigens present in their tumor. These vaccines are created by identifying tumor-specific antigens by sequencing the patient's tumor DNA and predicting which antigens are most likely to elicit an immune response. These antigens are then used to create a vaccine that is specific to that patient's tumor. On the other hand, predefined shared antigen vaccines are designed to target antigens that are commonly expressed in certain types of cancer. These vaccines can be used in multiple patients with the same type of cancer and are not personalised to each individual. The antigens used in these vaccines are selected based on their ability to induce an immune response and their potential to be recognised by T cells. Despite the promising potential of cancer vaccines, their clinical progress is limited, and skepticism surrounds their effectiveness. While there have been some examples of vaccines that have shown systemic regression of tumors and prolonged survival in small clinical trials, many trials have yielded marginal survival benefits. Challenges such as small trial sizes, resource-intensive approaches, and immune escape of heterogeneous tumors have hindered the field's progress. However, it is important to note that other immunotherapies, such as monoclonal antibodies and chimeric antigen receptor (CAR) T-cell therapies, have also faced challenges and setbacks before eventually achieving success. Therefore, cancer vaccines may also have the potential for eventual success, given their clear rationale and compelling preclinical data. To improve the efficacy of cancer vaccines, researchers are exploring various strategies. These include optimising antigen presentation and immune activation by using adjuvants or agonists of pattern-recognition receptors. Additionally, advancements in sequencing technologies and computational algorithms for epitope prediction allow for the identification of more specific tumor mutagens and the production of personalised neo-epitope vaccines. Neo-epitope vaccines are a type of personalised vaccine that target specific mutations or neo-epitopes present in a patient's tumor. These vaccines exploit the most specific tumor mutagens identified through computational methods and prioritise highly expressed neo-epitopes. They can be given with adjuvants to enhance their immunogenicity. Hence, cancer vaccines hold promise as a potential standard anti-cancer therapy. While their progress has been limited, a clear rationale and compelling preclinical data support their further development. Personalised vaccines targeting specific mutations or antigens present in a patient's tumor, as well as predefined shared antigen vaccines targeting commonly expressed antigens, are being explored. Future of mRNA vaccines mRNA vaccines have emerged as a promising alternative to traditional vaccine approaches due to their high potency, rapid development capabilities, and potential for low-cost manufacture and safe administration. Recent technological advancements have addressed the challenges of mRNA instability and inefficient in vivo delivery, leading to encouraging results in the development of mRNA vaccine platforms against infectious diseases and various types of cancer. Looking ahead, the future of mRNA vaccines holds great potential for further advancements and widespread therapeutic use. Efficient in vivo delivery of mRNA remains a critical area of focus for future development. Researchers are working on improving delivery systems to ensure targeted delivery to specific cells or tissues, thereby enhancing the effectiveness of mRNA vaccines. This includes the development of lipid nanoparticles, viral vectors, and other delivery mechanisms to optimize mRNA delivery and cellular uptake. The success of mRNA vaccines against infectious diseases and cancer has opened doors to exploring their potential in other areas of medicine. Future research may involve the development of mRNA vaccines for autoimmune disorders, allergies, and chronic diseases. The versatility of mRNA technology allows for the rapid adaptation of vaccine candidates to address various medical conditions. One exciting prospect for mRNA vaccines is their potential for personalised medicine. The ability to easily modify the genetic sequence of mRNA allows for the development of personalised vaccines tailored to an individual's specific genetic makeup or disease profile. This could revolutionise preventive medicine by enabling targeted immunisation strategies. Combining mRNA vaccines with other treatment modalities, such as immunotherapies or traditional therapies, could lead to synergistic effects and improved clinical outcomes. The unique properties of mRNA vaccines, such as their ability to induce potent immune responses and modulate the expression of specific proteins, make them attractive candidates for combination therapies. Continued advancements in manufacturing processes will be crucial for the widespread adoption of mRNA vaccines. Efforts are underway to optimise and scale up the production of mRNA vaccines, making them more accessible and cost-effective. This includes refining in vitro transcription reactions and implementing efficient quality control measures. The regulatory landscape surrounding mRNA vaccines will evolve as the field progresses. Regulatory agencies will need to establish guidelines and frameworks specific to mRNA vaccine development and approval. Ensuring safety, efficacy, and quality control will be essential to gain widespread acceptance and public trust in mRNA vaccines. Conclusion mRNA vaccines have shown great potential in revolutionising the field of medicine, particularly in the areas of personalised medicine and preventive medicine. The ability to easily modify the genetic sequence of mRNA allows for the development of personalised vaccines tailored to an individual's specific genetic makeup or disease profile. Furthermore, the unique properties of mRNA vaccines, such as their ability to induce potent immune responses and modulate the expression of specific proteins, make them attractive candidates for combination therapies. However, there are still challenges to overcome, such as ensuring safety, efficacy, quality control, addressing concerns regarding immunogenicity. Nonetheless, with continued advancements in manufacturing processes and regulatory guidelines, the future of mRNA vaccines holds great promise for further advancements and widespread therapeutic use. Efforts to improve in vivo delivery systems and explore the potential of mRNA vaccines in other areas of medicine, such as autoimmune disorders and chronic diseases, further contribute to the promising outlook for this technology. Written by Sara Maria Majernikova Related articles: Potential malaria vaccine / Bioinformatics in COVID vaccine production / Personalised medicine REFERENCES Lin, M.J., Svensson-Arvelund, J., Lubitz, G.S. et al. Cancer vaccines: the next immunotherapy frontier. Nat Cancer 3, 911–926 (2022). https://doi.org/10.1038/s43018-022-00418-6 Pardi, N., Hogan, M., Porter, F. et al. mRNA vaccines — a new era in vaccinology. Nat Rev Drug Discov 17 , 261–279 (2018). DOI: https://doi.org/10.1038/nrd.2017.243 Project Gallery
- The game of life | Scientia News
Maths till 18? No! All subjects till 18! Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link The game of life 11/07/25, 11:03 Last updated: Published: 20/11/23, 11:22 Maths till 18? No! All subjects till 18! I am a Maths graduate, a Maths teacher, and an all-rounder academic, yet in my twenties, when I began the process of buying a home, I had no idea where to start. I did not know how to get a mortgage, what shared ownership was, or when to get a solicitor involved. This is a problem, and this, I believe, is what needs to be taught from 16-18 years of age. The skills, opportunities, and options for young adults to simply move forward in this world. My suggestion: (for those who do not take A-Levels) To create a well-structured, virtual reality, cross-curricular running project about life, a little bit like an AI version of the ‘game of life.’ Students can begin the project in a virtual reality world of choice, and then slowly branch out depending on their interests. They can learn CV building skills , go to an AI job centre, choose the job they want to do and learn the skills for it by conducting research and completing online courses . At the same time within the project, students can be given a budget according to the job they are training for, in which they can forecast their savings and plan for the route that they would take in purchasing a property. Students would need to learn about shared ownership, the pros and cons of renting, the deposits needed for mortgage, all within a game format, like a PS5 game. This aspect of the project would be heavy with Maths. Students would be expected to write a final assessment piece summarising each of their decisions and why, which would include high levels of the English curriculum. To differentiate the project, we could ask students to use Geography, to find a country in the world where their skills may be more in demand and ask them to consider the possibility of relocating to another country for work, which would broaden the horizon of the project massively. They could look at tax laws in different countries, such as Dubai, and how that would benefit them in terms of salary, but what the importance of tax is in a country too. Students would get to explore countries which have free healthcare and schooling vs which countries do not. This would work on their analysis and deeper thinking skills. The game-like format of this project would be ideal for disengaged students who did not thrive with the traditional style of teaching in schools. We could include potential for earning points in the ‘game’ for each additional piece of research they conduct, and a real-life benefit to earning those points too, such as Amazon vouchers, as rewards. A project like this would enable all curriculums to get involved in, for students to understand the world better and a massive scope for AI, potentially asking Meta to design it, who are at the forefront of virtual reality. To make it work, the project would require teachers from all fields to come together to form a curriculum that is inclusive, considers British Values and mirrors the real-life that we live in today. There is potential for psychologist to be involved to ensure we are considering mental health implications as well as parents/guardians, who would need to be onboard with this too. In conclusion, I believe that 16-18 years do need guided learning that is standardised, but I do not think it is as simple as pushing Maths on to them. The future generation and their society will benefit from a holistic guided route to life, which will make them informed and educated individuals in topics that matter to THEM, based on THEIR lives, not chosen by us. Give students control over their education, over their lives... Written by Sara Altaf Project Gallery
- NGAL: A Valuable Biomarker for Early Detection of Renal Damage | Scientia News
How kidney damage can be detected Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link NGAL: A Valuable Biomarker for Early Detection of Renal Damage 10/07/25, 11:22 Last updated: Published: 04/04/24, 17:20 How kidney damage can be detected Nestled under the ribcage, the kidneys are primarily responsible for the filtration of toxins from the bloodstream and their elimination in urine. In instances of Acute Kidney Injury (AKI), however, this vital function is compromised. AKI is the sudden loss of kidney function, which is commonly seen in hospitalised patients. Because patients don’t usually experience pain or distinct symptoms, AKI is difficult to identify. Early detection of AKI is paramount to prevent kidney damage from progressing into more enduring conditions such as Chronic Kidney Disease (CKD). So, how can we detect AKI promptly? This is where Neutrophil Gelatinase-Associated Lipocalin (NAGL), a promising biomarker for the early detection of renal injury, comes into focus. Until recently, assessing the risk of AKI has relied on measuring changes in serum creatinine (sCr) and urine output. Creatinine is a waste product formed by the muscles. Normally, the kidney filters creatinine and other waste products out of the blood into the urine. Therefore, high serum creatinine levels indicate disruption to kidney function, suggesting AKI. However, a limitation of the sCr test is that it is affected by extrarenal factors such as muscle mass; people with higher muscle mass have higher serum creatinine. Additionally, an increase in this biomarker becomes evident once the renal function is irreversibly damaged. NGAL’s ability to rapidly detect kidney damage hours to days before sCr, renders it a more fitting biomarker to prevent total kidney dysfunction. Among currently proposed biomarkers for AKI, the most notable is NGAL. NGAL is a small protein rapidly induced from the kidney tubule upon insult. It is detected in the bloodstream within hours of renal damage. NGAL levels swiftly rise much before the appearance of other renal markers. Such characteristics render NGAL a promising biomarker in quickly pinpointing kidney damage. The concentration of NGAL present in a patient's urine is determined using a particle-enhanced laboratory technique. This involves quantifying the particles in the solution by measuring the reduced transmitted light intensity through the urine sample. In conclusion, the early detection of AKI remains a critical challenge, but NGAL emerges as a promising biomarker for promptly detecting renal injury before total loss of kidney function unfolds. NGAL offers a significant advantage over traditional biomarkers like serum creatinine- its swift induction upon kidney injury allows clinicians and healthcare providers to intervene before renal dysfunction manifests. Written by Fozia Hassan Related article: Cancer biomarkers and evolution REFERENCES Bioporto. (n.d.). NGAL . [online] Available at: https://bioporto.us/ngal/ [Accessed 5 Feb. 2024]. Branislava Medić, Branislav Rovčanin, Katarina Savić Vujović, Obradović, D., Duric, D. and Milica Prostran (2016). Evaluation of Novel Biomarkers of Acute Kidney Injury: The Possibilities and Limitations. Current Medicinal Chemistry , [online] 23(19). doi: https://doi.org/10.2174/0929867323666160210130256 . Buonafine, M., Martinez-Martinez, E. and Jaisser, F. (2018). More than a simple biomarker: the role of NGAL in cardiovascular and renal diseases. Clinical Science , [online] 132(9), pp.909–923. doi: https://doi.org/10.1042/cs20171592 . Giasson, J., Hua Li, G. and Chen, Y. (2011). Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a New Biomarker for Non – Acute Kidney Injury (AKI) Diseases. Inflammation & Allergy - Drug Targets , [online] 10(4), pp.272–282. doi: https://doi.org/10.2174/187152811796117753 . Haase, M., Devarajan, P., Haase-Fielitz, A., Bellomo, R., Cruz, D.N., Wagener, G., Krawczeski, C.D., Koyner, J.L., Murray, P., Zappitelli, M., Goldstein, S.L., Makris, K., Ronco, C., Martensson, J., Martling, C.-R., Venge, P., Siew, E., Ware, L.B., Ikizler, T.A. and Mertens, P.R. (2011). The Outcome of Neutrophil Gelatinase-Associated Lipocalin-Positive Subclinical Acute Kidney Injury. Journal of the American College of Cardiology , [online] 57(17), pp.1752–1761. doi: https://doi.org/10.1016/j.jacc.2010.11.051 . Moon, J.H., Yoo, K.H. and Yim, H.E. (2020). Urinary Neutrophil Gelatinase – Associated Lipocalin: A Marker of Urinary Tract Infection Among Febrile Children. Clinical and Experimental Pediatrics . doi: https://doi.org/10.3345/cep.2020.01130 . Vijaya Marakala (2022). Neutrophil gelatinase-associated lipocalin (NGAL) in kidney injury – A systematic review. International Journal of Clinical Chemistry and Diagnostic Laboratory Medicine , [online] 536, pp.135–141. doi: https://doi.org/10.1016/j.cca.2022.08.029 . www.nice.org.uk . (2014). Overview | The NGAL Test for early diagnosis of acute kidney injury | Advice | NICE . [online] Available at: https://www.nice.org.uk/advice/mib3 [Accessed 6 Feb. 2024]. Project Gallery
- Nikola Tesla, wireless electricity, and the failure of Wardenclyffe Tower | Scientia News
Tesla’s vision was to develop wireless power across the globe Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Nikola Tesla, wireless electricity, and the failure of Wardenclyffe Tower 10/07/25, 11:25 Last updated: Published: 04/09/24, 11:37 Tesla’s vision was to develop wireless power across the globe Nikola Tesla Nikola Tesla (1856-1943) was a Serbian-American engineer and one of the most brilliant inventors of his time. His discoveries on how to utilise alternating current laid the foundation for the industrial revolution and today makes up the majority of power distribution systems globally. Finding inspiration from his mother Duka Mandic, whom he called a first-class inventor and credited for passing on her gift of discovery*, he went on to make significant contributions to the development of X-ray technology, radio, and robotics, as well as inventing the brushless AC motor, the rotating magnetic field, neon lights, and remote control. However, despite his many revolutionary inventions and around 300 patents to his name, Tesla died poor and ultimately failed in his greatest pursuit: to develop a free system of clean, wireless, electric power. Wardenclyffe Tower, also known as the Tesla Tower, was the first step in Tesla’s ‘World Wireless System’, a system designed to wirelessly broadcast electrical power across the globe, based on 20th century knowledge of resonance, the earth’s conductivity, and the Tesla coil. The Tesla coil: working principle The Tesla coil, invented by Nikola Tesla in 1894, is an alternating current resonant transformer that produces a high voltage from a low current. The high voltage produces sparks of ‘lightning’ or electrical discharge which can power lightbulbs. This experiment was a key motivator for Tesla’s later works with Wardenclyffe, although today the main use of the Tesla coil is for filming, entertainment, and educational displays. In a typical transformer, the ratio of turns determines the output voltage. The resonant properties of the secondary coil in a Tesla coil allows the transformer to achieve much higher voltages. A high voltage power supply from the first transformer is applied to a small primary coil, creating a large magnetic field. Current flow through the primary coil charges up a capacitor until the voltage across it exceeds the breakdown voltage of the spark gap (air). The capacitor discharges through the secondary coil in the opposite direction. This reverse current flow induces a magnetic field around the primary coil in the opposite direction. The constant changing of field direction induces a current in the secondary coil and produces a voltage proportional to the winding ratio of the coils. The resulting high voltage produces arcs of electricity similar to lightning from the terminal (typically torus shaped to direct sparks outward and prevent interference). Despite the high voltage, these electric discharges only produce a very small current in people who interact with it because of the high impedance of the coil and are not dangerous unless a person has a pacemaker or other medical device that could be affected by the high voltages. The frequency of the current has little interaction with nerve cells. Wardenclyffe Tower Following the same principles as the small-scale Tesla coil, Tesla’s vision was to replicate this on a large scale to develop wireless power across the globe, so that information could be transmitted from one tower to another by resonance. His early design featured two towers placed next to each other, so that the gap between the two domes could act as a spark gap. After cost revisions, the tower was redesigned to feature the entire transmitter circuit in one tower (see Figure 2 ). Figure 3 shows Tesla’s plan for the World Wireless System. An oscillator tower stands at 187 feet with a large dome of conductive metals on top, and an iron root system 300 feet into the earth. When the tower and Tesla receivers are tuned to the same resonant frequency, Tesla theorised that energy could be efficiently transferred between them. After obtaining funding from financier J.P. Morgan, Wardenclyffe tower began construction in 1901 in Shoreham, New York. The 187-foot tower featured a large spherical terminal, which was intended to ionize the atmosphere and create a conductive path for the energy. Below ground, a network of metal rods and plates would transmit energy into the Earth, relying on the Earth’s conductivity to complete the circuit. The working of the tower fundamentally relied on two highly under-researched principles, which were: 1. Earth as a conductor : In 1899 before Tesla began work on Wardenclyffe, he studied the periodicity of lightning in Colorado Springs, USA, and discovered what he called earth resonance. He found that large electrical impulses travel longitudinally through the earth to the antipode and are reflected (i.e., ‘resonate’) creating terrestrial stationary waves. He planned to use the tower to send electrical energy through the ground, which would then be picked up by receivers located anywhere on the planet. 2. Air as a conductor: Although air is normally a good insulator, at high altitudes (the earth’s ionosphere) it becomes an excellent conductor of high frequencies and voltages. The tower was designed to generate extremely high-frequency alternating currents, however reaching the earth’s ionosphere would require an antenna of at least 15 miles tall. Tesla apparently discovered a way to bypass this but did not make his methods public. There was very little knowledge about these phenomena at the time and even today are still not fully validated. Why Wardenclyffe failed Tesla initially pitched the project to J.P. Morgan as a world system of wireless communication to send messages, reports, and secure military messages, and to broadcast news and music. Morgan invested around $150,000 which Tesla accepted and instead began working on wireless electricity transmission, despite the investment being far below a realistic sum for the cost of the project. As Wardenclyffe tower required frequent modifications to the tower’s design during construction as well as expensive materials, the project was very costly. At the same time, Guglielmo Marconi achieved his less ambitious and inexpensive aim of wirelessly communicating the letter ‘s’ in Morse code (using some of Tesla’s patents). Combined with the Panic of 1907 and realising Tesla’s primary aim was for electricity to be free worldwide, which would be difficult to monetise, J.P. Morgan withdrew financial support and Tesla was forced to abandon the project. The scientific community and further potential investors were also sceptical about the feasibility of wireless energy transmission particularly considering energy losses over long distances, which made it difficult to obtain further funding. At the same time as Wardenclyffe Tower was being developed, Tesla’s AC power distribution system was being implemented rapidly. The established infrastructure of wired electricity transmission made it even more difficult for Tesla's wireless system to gain traction and funding, and the tower was demolished in 1917 to satisfy Tesla’s debts. Conclusion Wardenclyffe tower was an ambitious and audacious project which ultimately was not financially feasible. Even with modern day technology, efficiency, safety, and economic considerations prevent the system being a practical reality. Nevertheless, Tesla was undeniably an ingenious inventor, and his futuristic and daring approach to engineering continues to inspire innovations as well as debate. Today the site of Wardenclyffe tower is home to the Tesla Science Centre, a memorial to Tesla’s life and work. Footnotes * A highly skilled and intelligent woman despite no formal education, she invented various household tools and devices like the loom and egg whisk. Written by Varuna Ganeshamoorthy Related articles: Transformers / Mobile networks / Electricity in the body REFERENCE Tesla, N., & Johnston, B. (1982). My inventions: the autobiography of Nikola Tesla. Project Gallery
- Beavers are back in Britain, ‘wood’ you like to know why? | Scientia News
Beavers alter their landscape through dams, canals, and felling trees Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Beavers are back in Britain, ‘wood’ you like to know why? 08/03/26, 18:09 Last updated: Published: 03/12/24, 12:05 Beavers alter their landscape through dams, canals, and felling trees This is article no. 3 in a series on animal conservation. Next article: Pangolins: from poached to protected . Previous article: Conserving the California condor Eurasian beavers ( Castor fiber ) transform freshwater habitats so dramatically that they are nicknamed ‘ecosystem engineers’. Their dam-building and tree-felling activities could reduce flood risk and increase biodiversity. After being hunted to extinction centuries ago, beavers have been reintroduced to Britain in both organised and illicit ways. This article will describe where they have been reintroduced in Britain, and the impact they could have. Ecological importance of beavers By building dams, Eurasian beavers alter their habitat - often for the better. Beaver dams are made from wood, stones, and mud. They control the flow of river water, reducing the risk of floods and droughts. The resulting slower water is a good place for amphibians to lay eggs and undergo the aquatic part of their life cycle. As water builds up behind the dam, it converts the area into a wetland - a source of drinking water for animals like bats and an excellent carbon sink. Meanwhile, invertebrates can lay eggs or hide from predators in the spaces within beaver dams ( Figure 1 ). Further up the food chain, beaver dams have complex effects on fish. Although the still water provides habitat for overwintering and rearing young, dams restrict the movement of fish species like salmon. However, most studies have concluded that beaver dams benefit freshwater biodiversity. Dams are not the only way Eurasian beavers improve their landscape. To access food and construction materials easily, beavers dig canals – which make the habitat better drained and more complex. Moreover, beavers gnaw at tree trunks and branches, sometimes knocking over entire trees. This creates deadwood where terrestrial invertebrates can live. Felling trees also allow sunlight to reach the river surface, promoting aquatic plant growth. When beavers gnaw at willow trees, they create propagules, which disperse along the beaver-made canal network and grow downstream. These new willow trees stabilise the river bank and further reduce the flood risk. Humans often trim back trees to stimulate their growth – called coppicing – but beavers do this free of charge. Coppicing, dam building, and canal digging are just a few ways beavers save the human costs of restoring and protecting natural habitats. Extinction and reintroduction However, Eurasian beavers used to be more exploited than appreciated. They were hunted for their fur, meat, and a secretion called castoreum, which is used in perfume and pharmaceuticals. Exactly when and how the beaver population went extinct from Britain is unclear, but the last written record of a beaver is from 1526 in Scotland and 1780 in England. Since then, the British turned wetlands into farmland and forgot about beavers … until recently. After centuries, beavers returned to Scotland in the late 2000s. A handful of beavers were spotted in River Tay about 15 years ago, after either an enclosure escape or an illegal release. There are 114 families in this illegal population, which has genetic origins in Germany. The first official beaver reintroduction occurred in Knapdale Forest, Scotland, in 2009 – but this population did not grow as quickly as the River Tay one. With scepticism, the reintroduction of Eurasian beavers to Scotland was deemed a success, and they became a ‘European Protected Species’ in Scotland in 2019. Seeing Eurasian beavers thriving in Scotland encouraged reintroduction plans in England. In the English county of Devon, River Otter showed signs of beaver presence since 2008 and breeding since 2013. Authorities were worried these illegally released beavers would spread foreign diseases to local wildlife, but the public campaigned to let the beavers be. Public affection for beavers led to the River Otter Beaver Trial in 2015, where two breeding pairs were released into the river after thorough health checks. By 2019, the number of breeding pairs grew to seven ( Figure 2 ). Therefore, beavers have successfully returned to England. Encouraged by the unofficial projects, in February 2025 the UK government announced a new programme to officially re-introduce beavers to England. This programme ensures existing beaver populations are carefully managed and new reintroductions are licensed. Since then, beavers have been legally released in Dorset (March 2025) and Cornwall (February 2026). Thus, the UK government has joined the British public in returning Eurasian beavers to their ancestral home. Conclusion Beavers alter their landscape through dams, canals, and felling trees. However, in Britain, they were hunted to extinction a long time ago. Although beavers first returned to England and Scotland illegally, they now live in healthy, growing populations supported by the government . Hopefully they will remain protected and loved by the public, helping us to restore wetlands and improve British freshwater biodiversity. Written by Simran Patel Related article: Vicuna conservation REFERENCES Andersen, L.H. et al. (2023) ‘Can reintroduction of beavers improve insect biodiversity?’, Journal of Environmental Management , 337, p. 117719. Available at: https://doi.org/10.1016/j.jenvman.2023.117719 . Brazier, R.E., Elliott, M., Andison, E., Auster, R.E., Bridgewater, S., Burgess, P., Chant, J., Graham, H., Knott, E., Puttock, A.K., Sansum, P., Vowles, A., (2020) ‘River Otter Beaver Trial: Science and Evidence Report’. Brazier, R.E. et al. (2021) ‘Beaver: Nature’s ecosystem engineers’, WIREs Water , 8(1), p. e1494. Available at: https://doi.org/10.1002/wat2.1494 . Campbell-Palmer, R. et al. (2020) ‘Beaver genetic surveillance in Britain’, Global Ecology and Conservation , 24, p. e01275. Available at: https://doi.org/10.1016/j.gecco.2020.e01275 . Department for Environment, Food & Rural Affairs and Natural England (2025) Wild beavers: Nature’s engineers to return to English waterways , GOV.UK . Available at: https://www.gov.uk/government/news/wild-beavers-natures-engineers-to-return-to-english-waterways (Accessed: 7 March 2026). Gaywood, M., Batty, D. and Galbraith, C. (2008) ‘Reintroducing the European Beaver in Britain’, British Wildlife , 19, pp. 381–391. Halley, D.J., Saveljev, A.P. and Rosell, F. (2021) ‘Population and distribution of beavers Castor fiber and Castor canadensis in Eurasia’, Mammal Review , 51(1), pp. 1–24. Available at: https://doi.org/10.1111/mam.12216 . Harris, S. (2025) ‘Wild beavers make historic return to England at Dorset nature reserve’, BBC News , 5 March. Available at: https://www.bbc.co.uk/news/articles/cwygxvzpkevo (Accessed: 7 March 2026). Hooker, J. et al. (2024) ‘Re-establishing historic ecosystem links through targeted species reintroduction: Beaver-mediated wetlands support increased bat activity’, Science of The Total Environment , 951, p. 175661. Available at: https://doi.org/10.1016/j.scitotenv.2024.175661 . Robinson, C. (2026) Two pairs of beavers released in Cornwall by wildlife trust , BBC News . Available at: https://www.bbc.co.uk/news/articles/cm2x9ndl4l9o (Accessed: 7 March 2026). Wilson, J.B., Bradley, J. and Bremner-Harrison, S. (2024) ‘The short-term impact of Eurasian beavers ( Castor fiber ) post-reintroduction on amphibian abundance and diversity in a lentic environment’, The Glasgow Naturalist , 28(2). Available at: https://doi.org/10.37208/tgn28224 . Project Gallery
- The Foremothers of Gynaecology | Scientia News
Lucy, Betsy, and Anarcha Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link The Foremothers of Gynaecology 10/07/25, 11:18 Last updated: Published: 05/03/24, 12:15 Lucy, Betsy, and Anarcha In collaboration with Dr Aakila Sammy from Publett for International Women's Month We have honoured remarkable women in science across the centuries. From Marie Curie's pioneering research on radioactivity in the 1800s to Henrietta Lacks's unintentional contribution to immortalised human cell lines in the 1900s and Rosalind Franklin's crucial work on the structure of DNA. Yet, even as their achievements shine, the names of their male counterparts, like Watson and Crick, often dominate the narrative. Let's journey back a century or two. Were the experiences of Lucy, Betsy, and Anarcha, the foremothers of gynaecology, similar? In the 19th century, Dr. James Marion Sims was celebrated as a surgical hero and the father of gynaecology. His fame stemmed from pioneering the first reliable surgery to treat vesicovaginal fistula, a severe childbirth complication causing a hole between a woman's bladder and vagina, leading to continuous urinary leakage and sometimes palliative care. Sims conducted his initial attempts at a small hospital behind his home in Montgomery, Alabama, focusing on enslaved African American women whom he housed. Over several years, he performed numerous operations on these women. Historical records indicate that 12 enslaved women underwent experimentation, with only three identified by name: Lucy, Betsy, and Anarcha. While Sims did treat white women, indicating a universal need for treatment, he probably began experimenting with black women first. Unfortunately, many records were destroyed after slavery ended, obscuring our understanding of these events. Consequently, many who suffered or displayed bravery may not receive proper historical recognition. But we're about to change that here! Slave owners often viewed enslaved women as valuable assets due to their potential to increase the slave population and, thus, the owner's wealth through labour. However, when complications arose during childbirth, rendering these women unable to work, slave owners sought alternative means to cover medical expenses and maintain profitability. This often involved leasing them to physicians like Sims for medical experimentation and treatment. Additionally, enslaved women who experienced complications during childbirth were often ostracised by their communities and left with no choice but to comply with the demands of their owners. While on lease, these teenage girls aged 17 to 19 worked for the Sims family and were subjected to experimentation, naked and restrained in front of an audience of male doctors. Lucy was the first of the three women to undergo Sims's experimental operation and remained conscious throughout the entire hour-long surgery. Post-surgery, Lucy developed an infection, and even though Sims was able to cure her infection, her injuries did not heal, which rendered the operation a failure. Betsy was operated on next with the same outcome minus the infection. Anarcha, operated on last, had the same results, but this did not stop Sims. Sims persisted in his experiments, even when his male assistants quit. He eventually trained the women to assist each other during surgeries, and over time, they became proficient enough to be considered medical practitioners in their own right. The turning point came after Anarcha's 30th surgery, where success was finally achieved. However, shortly afterwards, Sims closed his hospital and relocated north. The fate of the women after this point is noted as being returned to their masters, indicating the continued exploitation and oppression they faced despite their contributions to medical science. While Sims's legacy indeed sparks ethical concerns about consent, anaesthesia, and racism, it's vital to recognise the dire circumstances faced by the women he treated and their significant contributions to his work. Despite the troubling context of slavery, characterised by ambiguous consent, potential underuse of anaesthesia, and the enduring belief that black women could endure more pain (a misconception that persists in healthcare today), these women sought relief from their suffering. Or was it their slave owners who sought to protect their investment? In addition to recognising the systemic exploitation and dehumanisation suffered by enslaved individuals, it is important to celebrate the resilience and bravery of these women, who played a crucial role in advancing gynaecological understanding and techniques. Now, just a mile from the remaining Sims statue stands another monument honouring the true mothers of gynaecology: Lucy, Betsy, and Anarcha (by the artist and activist Michelle Browder). These teenagers played a profound role in shaping the field. It's imperative that we shift the narrative to acknowledge them as our foremothers in gynaecology when recounting this history. Their names deserve a place in the textbooks as well. -- Scientia News wholeheartedly thanks Aakila Sammy , co-founder and CEO of Publett , for this interesting article on the pioneering individuals in the field of gynaecology. We hope you enjoyed reading this International Women's Month Special piece! Follow them @Dr.Publett on Instagram and @Publett Limited on Linkedin for more information. -- Our last collaboration: Micro-chimerism and George Floyd's death Related articles: Female Nobel prize winners in physics and in chemistry / African-American women in cancer research / Women leading the charge in biomedical engineering / Endometriosis and PCOS / Postpartum depression in adolescent mothers REFERENCES National Library of Medicine. "Vesicovaginal fistula was a catastrophic complication of childbirth for many enslaved women between 1845 and 1849." Accessed 28th February 2024. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2563360/#:~:text=Vesicovaginal%20fistula%20was%20a%20catastrophic,women%20between%201845%20and%201849 . ProQuest. "Anarcha, Betsey, and Lucy: The Mothers of Modern Gynecology."Accessed 28th February 2024. https://www.proquest.com/openview/a02db7be4c84ed0066ed13e79513b6ad/1?pq-origsite=gscholar&cbl=41361 . Smithsonian Magazine. "A monument honouring enslaved women, known as the 'Mothers of Gynecology' has been erected."Accessed 28th February 2024. https://www.smithsonianmag.com/smart-news/mothers-of-gynecology-monument-honors-enslaved-women-180980064/ New York Historical Society. "To learn more about Anarcha, Betsey, and Lucy, visit the New York Historical Society's online exhibit, 'A Nation Divided: The Civil War Era"'.Accessed 28th February 2024. https://wams.nyhistory.org/a-nation-divided/antebellum/anarcha-betsy-lucy/ . Project Gallery
- Advancements in Semiconductor Laser Technology | Scientia News
What they are, uses, and future outlook Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Advancements in Semiconductor Laser Technology 11/04/26, 15:51 Last updated: Published: 23/06/24, 10:39 What they are, uses, and future outlook Lasers have revolutionised many fields starting from the telecommunications, data storage to medical diagnostics and consumer electronics. And among the semiconductor laser technologies, Edge Emitting Lasers (EEL) and Vertical Cavity Surface Emitting Lasers (VCSEL) emerged as critical components due to their unique properties and performance. These lasers generate light through the recombination of electrons and holes in a semiconductor material. EELs are known for their high power and efficiency and they are extensively used in fiber optic communications and laser printing. VCSELs on the other hand are compact and are used for applications like 3D sensing. Traditionally VCSELs have struggled to match the efficiency levels of EELs however a recent breakthrough particularly in multi junction VCSEL, has demonstrated remarkable efficiency improvements which place the VCSELs to surpass EELs in various applications. This article focuses on the basics of these laser technologies and their recent advancements. EELs are a type of laser where light is emitted from the edge of the semiconductor wafer. This design contrasts with the VCSELs which emit light perpendicular to the wafer surface. EELs are known for their high power output and efficiency which makes them particularly suitable for applications that require long-distance light transmission such as fiber optic communications, laser printing and industrial machining. EELs consist of an active region where electron hole recombination occurs to produce light. This region is sandwiched between two mirrors forming a resonant optical cavity. The emitted light travels parallel to the plane of the semiconductor layers and exits from the edge of the device. This design allows EELs to achieve high gain and power output which makes them effective for transmitting light over long distances with minimal loss. VCSELs are a type of semiconductor laser that emits light perpendicular to the surface of the semiconductor wafer unlike the EELs which emit light from the edge. VCSELs have gained popularity due to their lower threshold currents and ability to form high density arrays. VCSELs consist of an active region where electron-hole recombination occurs to produce light. This region is situated between two highly reflective mirrors which forms a vertical resonant optical cavity. The light is emitted perpendicular to the wafer surface which allows for efficient vertical emission and easy integration into arrays. Recent advancements in VCSEL technology marked a significant milestone in the field of semiconductor lasers. And in particular the development of multi junction VCSEL which led to the improvements in power conversion efficiency (PCE) of the laser. Research conducted by Yao Xiao et al. and team has demonstrated the potential of a multi junction VCSELs to achieve efficiency levels which were previously thought unattainable. This research focuses on cascading multiple active regions within a single VCSEL to enhance gain and reduce threshold current which leads to higher overall efficiency. The study employed a multi-junction design where several active regions are stacked vertically within the VCSEL. This design increases the volume of the gain region and lowers the threshold current density resulting in higher efficiency. Experimental results from the study revealed that a 15-junction VCSEL achieved a PCE of 74% at room temperature when driven by nanosecond pulses. This efficiency is the highest ever reported for VCSELs and represents a significant leap forward from previous records. Simulations conducted as part of the study indicated that a 20-junction VCSEL could potentially reach a PCE exceeding 88% at room temperature. This suggests that further optimization and refinement of the multi-junction approach could yield even greater efficiencies. The implications of this research are profound for the future of VCSEL technology. Achieving such high efficiencies places VCSELs as strong competitors to EELs, particularly in applications where energy efficiency and power density are critical. The multi junction VCSELs demonstrated in the study shows promise for a wide range of applications and future works may focus on optimising the fabrication process, reducing thermal management issues and exploring new materials to further enhance performance. Integrating these high-efficiency VCSELs into commercial products could revolutionise industries reliant on laser technology. Note: latest research shows development of photonic crystal surface-emitting lasers (PCSELs) for free-space optics, offering superior power and beam quality compared to traditional VCSELs. Written by Arun Sreeraj Related articles: The future of semi-conductor manufacturing / The search for a room-temperature superconductor / Advances in mass spectrometry Project Gallery
- Exposing medication to extreme heat | Scientia News
And its chemical effects Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Exposing medication to extreme heat 09/07/25, 15:09 Last updated: Published: 08/10/23, 17:18 And its chemical effects Introduction The majority of us look forward to when summer is just around the corner. It is a time for parents to start planning days off to be able to go on holiday with their kids to relax from their studies and enjoy sunsets at the beach. But for people who take medication, whether this just be a week-long course of antibiotics or for long-term conditions, summer may also be a chance for some negligence to occur. Specifically, alongside making sure you have applied SPF to protect your skin from the sun’s rays, you should also protect your medicine as well. This applies to both oral and non-oral drugs. Experts at The Montreal Children’s Hospital say that “many prescription drugs are very sensitive to changes in temperature and humidity”; in this article, we will therefore discuss the effect of extreme heat on drugs from a medicinal chemistry perspective. Factors affecting drug activity due to heat Certain drugs may begin to degrade before their expiry date if not stored appropriately. This affects the efficacy, which is the maximum biological response that is achievable with a certain drug. A dose-response curve can be plotted (see Figure 1 ) to show the relationship between the two variables; the label Emax refers to the efficacy. During hot weather, the structure of the drug can change and therefore unable to bind to its target, causing a lowered and shifted Emax to be seen. Simply put, the medication will not relieve your symptoms as effectively. Another physiochemical property of a drug that can be altered in the heat is the potency. Many people confuse this term with efficacy, but potency refers to the concentration of a drug required to achieve 50% of its maximum therapeutic effect i.e., half the Emax. Potency is therefore also known as EC50, which abbreviates for ‘half maximal effective concentration’. The lower the concentration needed, the more potent your drug is. Like reduced efficacy, the drug’s potency will also decrease in the heat due to altered chemical structure. For drugs like antibiotics, it is crucial to note that if potency is reduced significantly, it could risk infection spreading to other parts of the body as the medication will not fight off bacteria as well as it should. Potentially dangerous! Finally, drug absorption is when a drug moves into the bloodstream after being administered. The chemical structure of the drug and the environment in which it is present hugely affects this; for example, if a lipophilic (‘fat loving’) drug is also present in a lipophilic surrounding, fast absorption is seen as they work well with each other. As you have probably guessed, high temperatures outside of the body can reduce drug absorption due to the above factors mentioned, as the drug is not in its optimal structure to be absorbed effectively. Examples of medicine that are heat sensitive Here is a list of some medicines that require extra care to prevent the above: 1) Nitroglycerin – used to treat chest pains for those with cardiovascular disease. It is especially sensitive to heat or light as it degrades very fast. Dr. Sarah Westberg, a professor at The University of Minnesota College of Pharmacy, says you should follow the storage instructions and replace them regularly. 2) Some antibiotics – research has shown that ampicillin, erythromycin, and furosemide show a reduction in activity in the heat, although this was found after storing them for a year in a car with a temperature exceeding 25 degrees Celsius. Other antibiotics such as cefoxitin are shown to have some “stability in warmer climates”. 3) Levothyroxine – used to treat an underactive thyroid, also known as hypothyroidism. This drug should be stored between 15 to 30 degrees Celsius, although even 30 is quite high so the lower the temperature the better. Interestingly, levothyroxine isn’t heat sensitive itself, it is the fact that the body becomes sensitive to the drug and may make a person feel strange in the heat. 4) Metoprolol succinate – used to treat high blood pressure, also known as hypertension, and heart failure in emergencies . The ideal storage conditions for this drug are 15 to 30 degrees Celsius, like Levothyroxine. Key things to look out for with your medicine in the heat Below are the 2 main things you should be checking for before taking your medicine in the summer: 1) Change in colour – Light can initiate all sorts of reactions, such as oxidation. If, for example, your medicine that is normally white has now changed into a different colour, this suggests that a reaction has taken place within your drug and will not be effective when administered. 2) Change in texture – Similar to change in colour, if a normally solid, oral tablet has become soft then this also suggests that the medication will not be as effective when consumed. How you can prevent your medicine from degrading To make sure you do not contribute to wasting medicine, you should do the following: 1) Check storage information – for any medication that you take, this will let you know how to store them correctly. 2) Travel with care – do not pack prescription drugs into your luggage, as it will almost always become very warm due to the surrounding environment. Instead, carry your medicine with you with the labels still on. 3) Do not leave medicine in any vehicle – everyday vehicles such as cars tend to get warm after a period , which can affect the colour and texture of your medicine. 4) Careful deliveries – for those who have their medicine delivered to them, you can request for your local pharmacy to deliver your medicine in temperature-controlled packages. Summary As discussed, chemicals in the majority of over-the-counter prescription drugs are heat sensitive and should therefore be handled with care, to prevent degradation of the drug. Changes in colour and texture are signs of degradation, which result in loss of efficacy, absorption, and potency. However, many other pharmacological factors interfere, so scientists especially involved in drug synthesis should (or continue to) take great precautions with the manufacturing process. Drugs are costly to make and require a lot of time, so the takeaway is to store them correctly! You should contact your pharmacist if you are still unsure about your prescription(s). Written by Harsimran Kaur Sarai Project Gallery










